Dr. Edward Libby is a hematologist at the Seattle Cancer Care Alliance and the University of Washington. His practice and research focus are in clinical trials for patients with multiple myeloma, Waldenstrom's Macroglobulinemia, and amyloidosis.
Get to know your patient and their family. Listen, listen, and then listen some more to what your patient has to say. We are taking this journey together. Focus on being there for your patients. Humility is key.
Thomas Merton wrote… "Pride makes us artificial and humility makes us real."
- Multiple myeloma
- Plasma cell leukemia
- Waldenstrom’s macroglobulinemia
- POEMS Syndrome
- Associate Professor, Medical Oncology Division, University of Washington School of Medicine
- Associate Member, Clinical Research Division, Fred Hutch
- The University of Texas Medical School at Houston, 1984
- Residency and Chief Residency: University of New Mexico School of Medicine, 1984-88
- Fellowship: University of New Mexico Cancer Center, 2002-2005
Dr. Edward Libby realized early on that doctors who treat cancer often have the most unique and deep relationships with patients. “We are happy when there's good news and we cry when things aren’t going well,” he says. “The combination of science, art, and humanism in medicine is—in my opinion—best exemplified in oncology.”
Dr. Libby joined SCCA because it allows him to unite his passions for treating patients and advancing clinical research. “Combining research with patient care is what gets me up in the morning,” he says. “Scientific research studies are absolutely critical if we are to advance the treatment of patients with cancer. The goals of clinical research are to cure more patients, prolong patients' lives when cures are not possible, reduce the side effects of treatment, and preserve the quality of patients' lives.”
His research is focused on finding new and improved treatments for patients with multiple myeloma, Waldenstrom's macroglobulinemia, amyloidosis, and lymphoma. "I am fortunate to be working exclusively in the specialty area of hematologic malignancies because some of the most important and groundbreaking advances in the treatment of all patients with cancer are based on initial research breakthroughs produced for patients with blood cancers" he says.
Outside of work, Dr. Libby enjoys jogging, going to the gym, music, and art. Since moving to Seattle, he has also joined a sailboat club on Puget Sound and enjoyed the Seattle sports scene by attending Mariners, Sounders, and Seahawk games. “I plan to see the Huskies play this season, too,” he says. Family and friends are important to Dr. Libby, so he spends as much time as possible with his kids and his “close compadres….that's Spanish for friends,” he says with a grin.